Stock Idea: $MDGL (8 Feb 2023)
MDGL- Big 300% move after successful trials for company's liver disease drug
- Been consolidating. Failed to breakout in Jan from tight range
- Inside-day bar on Tue, coming after bullish reversal candle on Mon. Potential early entry
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。